BRIDGEWAY CAPITAL MANAGEMENT, LLC - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 88 filers reported holding NEWLINK GENETICS CORP in Q4 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q4 2019$274,000
+207.9%
108,400
+93.9%
0.00%
+300.0%
Q3 2019$89,000
-63.7%
55,900
-45.6%
0.00%
-50.0%
Q3 2018$245,000
-49.9%
102,7000.0%0.00%
-60.0%
Q2 2018$489,000
-34.4%
102,7000.0%0.01%
-37.5%
Q1 2018$745,000
-8.1%
102,700
+2.7%
0.01%
-11.1%
Q4 2017$811,000
-20.3%
100,0000.0%0.01%
-25.0%
Q3 2017$1,018,000100,0000.01%
Other shareholders
NEWLINK GENETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders